20 results
6-K
EX-99.1
MOR
Morphosys AG
25 Jan 22
MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards’ Gender Equality Index Report
7:16am
in European Women on Boards’ Gender Equality Index Report
MorphoSys AG (FSE: MOR; NASDAQ: MOR) was acknowledged as a Best Practice Leader in the European … Women on Boards’ Gender Equality Index Report, ranking number one in Germany and number two among European healthcare companies for female
6-K
EX-99.1
MOR
Morphosys AG
16 Mar 22
Current report (foreign)
5:13pm
Employees (in %) Employees2 by Gender (December 31, 2021) 458 U.S. Germany female male 59 43 Nations732 2021 415842 Total Employees (Number) Employees … for reasons of race, color, religion, gender, gender identity, national origin, age, sexual orientation, marital or protected veteran status, medical condi
6-K
EX-99.1
MOR
Morphosys AG
23 Jun 22
First Quarter Interim Statement JANUARY – MARCH
6:30am
in the European Women on Boards' Gender Equality Index Report.
MorphoSys – I/2022
Group Interim Statement
MorphoSys Product Pipeline of Own Clinical … for female representation at leadership level in the European Women on Boards' Gender Equality Index Report and was acknowledged as a Best Practice Leader
6-K
MOR
Morphosys AG
25 Jan 22
MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards’ Gender Equality Index Report
7:16am
in Germany for Female Representation at Leadership Level in European Women on Boards’ Gender Equality Index Report
SIGNATURES
Pursuant
6-K
EX-99.1
MOR
Morphosys AG
13 Mar 24
Non-Financial Group Report 2023
4:12pm
, promotion, or other employment practices for reasons of race, color, religion, gender, gender identity, national origin, age, sexual orientation … adds to our identity as a truly global organization. Employees1 by Gender (December 31, 2023) Employees1, 2 by Region (December 31, 2023) Our
6-K
EX-99.1
1jfgule6 kf6ou0myv0x
16 Mar 22
2021 Annual Report A nn ua l R ep or t 20 21
4:55pm
6-K
EX-99.1
cclu7eovumthoq34g
13 Mar 24
Current report (foreign)
4:08pm
6-K
EX-99.1
otwedeu1c5u2jy
15 Mar 19
2018 annual report Morphosys Engineering the Medicines of Tomorrow
6:27am
6-K
EX-99.1
9d3yba07j5
22 Mar 21
Current report (foreign)
12:42pm
6-K
EX-99.1
lclijlo1d4ojhv mspl
20 Mar 24
Current report (foreign)
4:12pm
6-K
EX-99.1
ng5l4q
20 Mar 20
Current report (foreign)
2:15pm
6-K
EX-99.3
0u8q09bl9kil
7 Feb 24
MorphoSys Enters into Business Combination Agreement to be
6:57am
20-F
yqb mj37eoshfroq9o
13 Mar 19
Annual report (foreign)
5:13pm
6-K
EX-99.1
cj4o z0qthvj3cqbv
23 Mar 22
Current report (foreign)
4:15pm
6-K
EX-99.1
rowmuh9
23 Mar 21
Current report (foreign)
3:53pm
6-K
EX-99.1
oss9l3kcf un9
27 Mar 20
Current report (foreign)
3:29pm
6-K
EX-99.1
lfrugdq5b0u
21 Mar 19
Current report (foreign)
6:14am
- Prev
- 1
- Next